Celestone and candidiasis Patient Reports February 11, 2012

Celestone Side Effects Report #4585565-1
Celestone side effect was reported by a Physician from on Feb 04, 2005. Female patient, 63 years of age, weighting 99.21 lb, was diagnosed with brain oedema, anaplastic astrocytoma and was treated with Celestone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial sepsis, blood glucose increased, brain oedema, c-reactive protein increased, candidiasis, disseminated intravascular coagulation. Celestone dosage: unknown. During the same period patient was treated with TEMOZOLOMIDE CAPSULES, TEMOZOLOMIDE CAPSULES, TEMOZOLOMIDE CAPSULES, AMLODIPINE BESYLATE, GASTER, SELBEX, PURSENNID. Patient was hospitalized. Patient recovered.

Celestone Side Effects Report #4592588-5
Celestone side effect was reported by a Physician from on Feb 15, 2005. Female patient, 63 years of age, weighting 99.21 lb, was diagnosed with brain oedema, anaplastic astrocytoma and was treated with Celestone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, candidiasis, disseminated intravascular coagulation, endotoxic shock, herpes zoster, multi-organ failure. Celestone dosage: unknown. During the same period patient was treated with TEMOZOLOMIDE, AMLODIPINE BESYLATE, GASTER, SELBEX, PURSENNID. Patient was hospitalized. Patient recovered.

Celestone Side Effects Report #4678638-6
Celestone side effect was reported by a Physician from on May 18, 2005. Female patient, 63 years of age, weighting 99.21 lb, was diagnosed with brain oedema, anaplastic astrocytoma and was treated with Celestone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection , blood glucose increased, candidiasis, disseminated intravascular coagulation, herpes zoster, pancytopenia. Celestone dosage: 6-4 MG QD* ORAL. During the same period patient was treated with TEMOZOLOMIDE CAPSULES, TEMOZOLOMIDE CAPSULES, TEMOZOLOMIDE CAPSULES, AMLODIPINE BESILATE, GASTER, SELBEX CAPSULES, PURSENNID. Patient was hospitalized. Patient recovered.

Celestone Side Effects Report #4685593-1
Celestone side effect was reported by a Physician from on May 26, 2005. Female patient, 63 years of age, weighting 99.21 lb, was diagnosed with brain oedema, anaplastic astrocytoma and was treated with Celestone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood glucose increased, c-reactive protein increased, candidiasis, disease progression, disseminated intravascular coagulation. Celestone dosage: unknown. During the same period patient was treated with TEMOZOLOMIDE CAPSULES, TEMOZOLOMIDE CAPSULES, TEMOZOLOMIDE CAPSULES, AMLODIPINE BESILATEELTS, GASTER, SELBEX CAPSULES, PURSENNID. Patient was hospitalized. Patient died on 05/04/2005.


Celestone Side Effects Report #4690145-3
Celestone side effect was reported by a Physician from on June 07, 2005. Female patient, 63 years of age, weighting 99.21 lb, was diagnosed with brain oedema, anaplastic astrocytoma and was treated with Celestone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, bacterial infection , blood glucose increased, candidiasis, disseminated intravascular coagulation, endotoxic shock. Celestone dosage: unknown. During the same period patient was treated with TEMOZOLOMIDE CAPSULES, TEMOZOLOMIDE CAPSULES, AMLODIPINE BESILATE, GASTER, SELBEX CAPSULES, PURSENNID, BAKTAR. Patient was hospitalized. Patient died on 05/04/2005.

Celestone Side Effects Report #4742101-4
Celestone side effect was reported by a Physician from JAPAN on July 29, 2005. Female patient, 63 years of age, weighting 99.21 lb, was diagnosed with brain oedema, anaplastic astrocytoma and was treated with Celestone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood glucose increased, brain oedema, c-reactive protein increased, candidiasis, disease progression, disseminated intravascular coagulation. Celestone dosage: 6-4 MG QD* ORAL. During the same period patient was treated with TEMODAL, BETAMETHASONE DIPROPIONATE, AMLODIPINE BESILATE, GASTER. Patient was hospitalized. Patient died on 05/04/2005.